University of Tabuk | Saudi Arabia
Dr. Mohammad Zubair, Ph.D. (Microbiology), PDF (Medicine), MRSB (UK), and NZIMLS (New Zealand), is an accomplished Associate Professor of Medical Microbiology at the Faculty of Medicine, University of Tabuk, Saudi Arabia. With a prolific academic and research career, Dr. Zubair has published 50 documents with 1,339 citations by 1,250 documents and holds an h-index of 16, reflecting the broad impact of his scholarly contributions in microbiology, infectious diseases, and biomedical sciences. His primary research interests lie in diabetic wound infections, antimicrobial resistance, biofilm inhibition, and nanomedicine, where his groundbreaking work has advanced understanding of biofilm-forming pathogens and novel therapeutic interventions. He has authored books, book chapters, and high-impact journal articles in leading journals such as Diabetes & Metabolic Syndrome, Frontiers in Microbiology, Saudi Journal of Biological Sciences, and Plos One. Dr. Zubair’s research on biofabrication of nanoparticles and the clinical management of diabetic foot ulcers has earned international recognition and multiple patents. He is a member of several prestigious scientific societies including the Royal Society of Biology (UK), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), and the New Zealand Institute of Medical Laboratory Sciences (NZIMLS). As General Supervisor of the Phytomedicine Lab at Prince Fahad Bin Sultan Center for Biomedical Research, he leads projects focused on bioprospecting of natural products and biofilm control strategies. His academic leadership extends to curriculum innovation and student mentorship at the University of Tabuk. Dr. Zubair has received numerous honors including the Excellence in Research Award (University of Tabuk), Best Book and Best Poster Awards, and the Marvil Levin Best Research Award from the American Diabetes Association. Through his scientific rigor, innovative vision, and dedication to medical education and research, Dr. Mohammad Zubair has established himself as a leading figure in medical microbiology and biomedical innovation, making significant contributions to global health and translational research in infectious disease management.
Featured Publications
Ullah, A., Waqas, M., Duran, S., Rehman, N. U., Rahman, S. U., Abdellattif, M. H., Jan, A., Zubair, M., Ahmed, M. M., Khan, A., et al. (2025). Identifying potent natural inhibitors of the hepatitis C virus NS3 protein using multiple computational and molecular approaches. Computers in Biology and Medicine, 183, 110801.
Mehmood, A., Xue, Y. Z., Yassin, H. M., Zubair, M., Rahmat, S. A., & Ahmad, A. (2025). LINE-1 retrotransposon activation drives age-associated inflammation via cytoplasmic cDNA-STING/type I interferon signalling: Therapeutic potential of reverse transcriptase inhibition. Współczesna Onkologia, 29(1), Article 152369.
Zubair, M., & Albalawi, Y. (2025). The role of biogenic aluminium oxide nanoparticles (Al₂O₃NPs) synthesised from Solanum virginianum L. in combating microbial vaginal pathogens. Scientific Reports, 15, 19268.
Ali, M., Irfan, H. M., Alamgeer, A., Ullah, A., Abdellattif, M. H., Elodemi, M., Zubair, M., Khan, A., & Al-Harrasi, A. (2025). Therapeutic role of Crateva religiosa in diabetic nephropathy: Insights into key signaling pathways. PLOS ONE, 20(11), e0324028.
Zubair, M., Fatima, F., Alatawy, R., Albalawi, Y., Abbas, K., Alhazmi, K., Alam, M., Mustafa, M., & Mesaik, M. A. (2025). Antimicrobial and antibiofilm activity of biogenic MgO nanoparticles and extract from Hibiscus sabdariffa against multidrug resistance. ChemistrySelect, 10(11), e202502412.